AVEVA (Schneider Electric) Case Studies Wonderware Success Story: Xcellerex

	Wonderware Success Story: Xcellerex AVEVA (Schneider Electric)

Wonderware Success Story: Xcellerex

AVEVA (Schneider Electric)

Technology Category	Application Infrastructure & Middleware - Data Exchange & Integration Platform as a Service (PaaS) - Data Management Platforms
Applicable Industries	Life Sciences Pharmaceuticals
Applicable Functions	Discrete Manufacturing Product Research & Development
Use Cases	Manufacturing System Automation Predictive Maintenance
Services	Software Design & Engineering Services System Integration
Challenge	Xcellerex, a company revolutionizing the way biopharmaceuticals and vaccines are developed, manufactured, and commercialized, faced the challenge of integrating complex technology with ultra-high levels of functionality. The company aimed to create a biomanufacturing platform that employs single-use technology, controlled environment modules, process automation, and electronic batch records. The goal was to address the growing demands in the biomedical market space for more effective biopharmaceutical manufacturing processes and develop a solution that would define a model for improving how biopharmaceuticals, vaccines, and other therapeutics are developed, manufactured, and commercialized. Read More
About Customer	Xcellerex is a life sciences company based in Marlborough, Massachusetts. The company is revolutionizing the way biopharmaceuticals and vaccines are developed, manufactured, and commercialized. Xcellerex has developed FlexFactory, a manufacturing platform designed to enhance the production of critical biopharmaceutical products. The company identified the need to integrate single-use technology, controlled environment modules, process automation, and electronic batch records into its FlexFactory platform. Xcellerex aims to offer customers significant improvements in production processes, including 70 percent faster deployment, 75 percent reduced capital investment, and an unmatched level of flexibility. Read More
Solution	Xcellerex selected Wonderware System Platform as the backbone of the complete biopharmaceutical automation software application. Other Schneider Electric Software included Wonderware InTouch as the HMI, Wonderware InBatch to provide effective batching operations, and Wonderware Historian to serve as the system’s powerful application to maintain historical production data. The integration of Wonderware software components has enabled Xcellerex to offer customers significant improvements in production processes. Wonderware software gives Xcellerex a more efficient technology framework, while ensuring the highest quality in biomanufacturing. The software solution also includes Wonderware InBatch, which enables users to deploy batch functions that adhere to the ISA S88 flexible batching standard. Read More Log in to view content
Contents

Technology Category

Application Infrastructure & Middleware - Data Exchange & Integration

Platform as a Service (PaaS) - Data Management Platforms

Applicable Industries

Life Sciences

Pharmaceuticals

Applicable Functions

Discrete Manufacturing

Product Research & Development

Use Cases

Manufacturing System Automation

Predictive Maintenance

Services

Software Design & Engineering Services

System Integration

Challenge

Xcellerex, a company revolutionizing the way biopharmaceuticals and vaccines are developed, manufactured, and commercialized, faced the challenge of integrating complex technology with ultra-high levels of functionality. The company aimed to create a biomanufacturing platform that employs single-use technology, controlled environment modules, process automation, and electronic batch records. The goal was to address the growing demands in the biomedical market space for more effective biopharmaceutical manufacturing processes and develop a solution that would define a model for improving how biopharmaceuticals, vaccines, and other therapeutics are developed, manufactured, and commercialized.

About Customer

Xcellerex is a life sciences company based in Marlborough, Massachusetts. The company is revolutionizing the way biopharmaceuticals and vaccines are developed, manufactured, and commercialized. Xcellerex has developed FlexFactory, a manufacturing platform designed to enhance the production of critical biopharmaceutical products. The company identified the need to integrate single-use technology, controlled environment modules, process automation, and electronic batch records into its FlexFactory platform. Xcellerex aims to offer customers significant improvements in production processes, including 70 percent faster deployment, 75 percent reduced capital investment, and an unmatched level of flexibility.

Solution

Xcellerex selected Wonderware System Platform as the backbone of the complete biopharmaceutical automation software application. Other Schneider Electric Software included Wonderware InTouch as the HMI, Wonderware InBatch to provide effective batching operations, and Wonderware Historian to serve as the system’s powerful application to maintain historical production data. The integration of Wonderware software components has enabled Xcellerex to offer customers significant improvements in production processes. Wonderware software gives Xcellerex a more efficient technology framework, while ensuring the highest quality in biomanufacturing. The software solution also includes Wonderware InBatch, which enables users to deploy batch functions that adhere to the ISA S88 flexible batching standard.

Impact #1	Xcellerex’s FlexFactory enables companies to achieve significant cost savings in several areas, including a capital investment reduction that can exceed 60 percent.
Impact #2	The solution decreases the facility space required by 40 percent, lessens water usage and waste by 85 percent.
Impact #3	FlexFactory reduces deployment time from three to five years to 12 to 18 months, which enables the production of high value products two to four years sooner than traditional technology.

Impact #1

Xcellerex’s FlexFactory enables companies to achieve significant cost savings in several areas, including a capital investment reduction that can exceed 60 percent.

Impact #2

The solution decreases the facility space required by 40 percent, lessens water usage and waste by 85 percent.

Impact #3

FlexFactory reduces deployment time from three to five years to 12 to 18 months, which enables the production of high value products two to four years sooner than traditional technology.

Benefit #1	Capital investment reduction that can exceed 60 percent.
Benefit #2	Decrease in the facility space required by 40 percent.
Benefit #3	Lessen water usage and waste by 85 percent.

Benefit #1

Capital investment reduction that can exceed 60 percent.

Benefit #2

Decrease in the facility space required by 40 percent.

Benefit #3

Lessen water usage and waste by 85 percent.

Download PDF Version

Overview

Wonderware Success Story: Xcellerex

Operational Impact

Quantitative Benefit